((自动化翻译由路透提供，请见免责声明 ))
12月9日 - ** 医疗设备制造商AngioDynamics 的股价盘前上涨12.6%，至7.88美元。
** ANGO表示，美国食品和药物管理局（FDA） (link)，批准了其治疗前列腺癌的医疗设备。
** 该设备名为NanoKnife系统，利用电脉冲在癌细胞膜上开出小孔来消灭癌细胞。
** 全球每年有 150 万男性罹患前列腺癌 - ANGO
** 截至上次收盘，该股今年累计下跌 10.7
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.